This job has expired

You will need to login before you can apply for a job.

Investigator I (LNP Process & Chemistry)

CSL Behring
Start date
Sep 1, 2023

View more

Job Details

Job Description


As the Investigator I in the RNA Vaccine Process & Chemistry group, you will help design and optimize the next generation of RNA vaccines. Specifically, you will improve the performance of the lipid nanoparticle (LNP)for mRNA vaccine development by supporting the screening of new lipids and the optimization of LNP process. You will also design and implement experiments to better understand and expand the RNA delivery platform.

  • Lipid screening and evaluation to improve LNP performance for mRNA vaccine delivery.
  • Provides expertise to improve the scientific understanding of LNP process of mRNA vaccine.
  • Performance of mRNA lipid nanoparticle production to support preclinical studies.
  • Collaborate with internal and external partners in developing next-generation delivery systems for mRNA vaccines and beyond.
  • Prepare data summary presentation, compile data, and author technical reports.
  • Support to maintain functional laboratory equipment, manage laboratory databases and follow HSE regulation.
  • PhD in Chemistry, Chemical Engineering, Pharmaceutical Science, or other related fields with 0+ years of postdoc experience.
  • Academic or industry experience with lipid chemistry or LNP is required.
  • Experience with LNP characterization techniques such as DLS-Zeta measurement and electron microscopy is required.
  • Experience with common laboratory and analytical techniques, such as UV/vis spectroscopy, HPLC, fluorescence assays is preferred.
  • The ability to produce accurate and reproducible results while working on multiple tasks is required.
  • The ability to work in teams with written/oral communication skills are required.

About Us

Our Benefits

Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join Seqirus.

About Seqirus

Seqirus is part of CSL Limited (ASX: CSL). As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. Learn more about Seqirus.

We want Seqirus to reflect the world around us

As a global organisation with employees in 35+ countries, CSL embraces diversity, equity and inclusion. Learn more about Diversity, Equity & Inclusion at Seqirus.

Do work that matters at Seqirus!


As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research. 

CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential. 

CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries. 
For more information visit Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!

Stock Symbol: CSL

Stock Exchange: Australian Securities Exchange

Company info
1020 First Avenue
King of Prussia
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert